Homeopathy 2023; 112(04): 288-290
DOI: 10.1055/s-0043-1768917
Letter to the Editor

Arsenicum album 30C: An Unlikely Source of Liver Toxicity

Authors

  • Debadatta Nayak

    1   Scientist-III, Epidemic Cell, Central Council for Research in Homoeopathy, New Delhi, India
  • Anupriya Chaudhary

    2   Scientist-II, Clinical Research, Central Council for Research in Homoeopathy, New Delhi, India
  • Ishant Arora

    3   Department of Homoeopathy, Central Council for Research in Homoeopathy, New Delhi, India
  • Roja Varanasi

    4   Scientist-III, Clinical Research, Central Council for Research in Homoeopathy, New Delhi, India
Preview

The AYUSH system of medicine continues to play an integral role in the management of coronavirus disease 2019 (COVID-19) infection in India. Whilst several clinical research studies have indicated the possible beneficial effects of homeopathic Arsenicum album in COVID-19 infection, supporting the advisory for its use by the Ministry of AYUSH, India, the latter has faced a substantial amount of criticism from other systems of medicine based on biased observations and insufficient literature review.

Recently, the journal Cureus published a clinical case-series paper entitled “Dangerous Placebo during the COVID-19 Pandemic: A Series of Homoeopathic Arsenicum Album-Induced Liver Injury.”[1] The article presents three cases of acute liver injury, including one patient with underlying non-alcoholic steatohepatitis (NASH) cirrhosis who later died, apparently due to the consumption of Arsenicum album 30C for COVID-19 prevention. We examined the data presented and the claims of the Cureus paper, identifying several discrepancies and concerns in its content.



Publication History

Received: 20 January 2023

Accepted: 22 March 2023

Article published online:
16 June 2023

© 2023. Faculty of Homeopathy. This article is published by Thieme.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany